DOI: 10.1016/j.clnesp.2016.02.045
View full text
Javier D. Lasala, Jagtar Singh Heir, Gabriel E. Mena, Alpa M. Nick, Larissa A. Meyer, Maria D. Iniesta, Mark F. Munsell, Gloria Salvo, Juan P. Cata, Ifeyinwa Ifeanyi, Vijaya Gottumukkala, Katherine E. Cain, Pedro T. Ramirez

Abstract: Objectives: To describe a process change and evaluate compliance with use of preventive analgesia and deep venous thromboembolic (DVT) prophylaxis in an ESRP pathway following implementation of order set. Methods: The ESRP at MD Anderson was initiated in the Department of Gynaecologic Oncology in November 2014. We used the following medications for preventive analgesia; pregabalin (neuropathic pain), celecoxib (non-steroidal anti-inflammatory), and tramadol (mu-opioid receptor, synthetic opioid). An order set …

expand abstract